Journey Medical (DERM) Interest & Investment Income (2022 - 2026)
Journey Medical (DERM) posted Interest & Investment Income of $157000.0 for Q1 2026, up 6.08% on a QoQ basis from $148000.0 in Q4 2025, and up 5.37% year-over-year from $149000.0 in Q1 2025.
Journey Medical (DERM) Interest & Investment Income (2022 - 2026) Analysis & Trends
Journey Medical's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $157000.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 5.37% year-over-year to $157000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $597000.0 (down 13.35% YoY) and the FY2025 annual result came in at $589000.0, down 22.19% from the prior year.
- Interest & Investment Income was $157000.0 for Q1 2026 at Journey Medical, up from $148000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $217000.0 in Q1 2024 and bottomed at $3000.0 in Q1 2022.
- A 5-year average of $110882.4 and a median of $138000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 3966.67% — and 2025, when it slumped 31.34%.
- Journey Medical's Interest & Investment Income stood at $50000.0 in 2022, then soared by 126.0% to $113000.0 in 2023, then surged by 69.03% to $191000.0 in 2024, then dropped by 22.51% to $148000.0 in 2025, then advanced by 6.08% to $157000.0 in 2026.
- Business Quant data shows DERM's Interest & Investment Income at $157000.0 in Q1 2026, $148000.0 in Q4 2025, and $154000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Journey Medical | 169.02 Mn | 141.80 Mn | 9.70 Mn | 157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 191,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 161,000.00 |
| Mar 31, 2024 | 217,000.00 |
| Dec 31, 2023 | 113,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 79,000.00 |
| Mar 31, 2023 | 122,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 3,000.00 |